Skip to main content
Search
Search
Anywhere
Quick Search anywhere
Enter words / phrases / DOI / ISBN / keywords / authors / etc
Search
Advanced Search
Login
Skip main navigation
Open Drawer Menu
Close Drawer Menu
Home
Journal of Comparative Effectiveness Research
Journal of Patient Centricity
The Evidence Base
Journal of Comparative Effectiveness Research
ISSN (print): 2042-6305
•
ISSN (online): 2042-6313
•
Impact Factor: 2.8 (2025)
•
CiteScore: 4.2 (2025)
Open Access
•
Submit an article
For Authors
Sign up for Alerts
Visit The Evidence Base
HOME
LATEST ARTICLES
CURRENT ISSUE
ARCHIVE
ABOUT
Journal Information
Editorial Board
Editorial Policies
Plain Language Summaries
CONTRIBUTE
Author Guidelines
Reviewer Guidelines
Open Access
Submit an Article
Share
Share on
Facebook
X
LinkedIn
Reddit
Bluesky
Latest
On the economics of broadly neutralizing monoclonal antibodies for HIV prevention in high-income countries
Blythe Adamson
,
Huub C Gelderblom
,
Maurine D Miner
, and
Lawrence Corey
1 Oct 2026
Considerations for understanding systematic reviews and network meta-analyses in neurological applications: a review and critique in chronic migraine
Jessica Ailani
,
Christopher D Saffore
,
Ifeanyi Ubamadu
,
Stefano Perni
,
Elizabeth Chertavian
,
Eric B Collins
, and
Si-Tien Wang
22 Sep 2026
Indirect treatment comparison of odevixibat and maralixibat for the treatment of cholestatic pruritus in patients with Alagille syndrome
Emmanuelle Kaltenbach
,
Alice Guiraud-Diawara
,
Jérémie Schwarzbard
, and
Cécile Artaud
18 Sep 2026
Rigorous, transparent and inconclusive: what Europe’s first joint clinical assessment reveals about a framework trying to serve everyone
Ramiro Gilardino
,
Antonella Cardone
, and
Carlos M Cossio
17 Sep 2026
Open Access
Submit an Article
Most Cited
Most read
Framework and guidance for implementing patient-reported outcomes in clinical practice: evidence, challenges and opportunities
Ian Porter
,
Daniela Gonçalves-Bradley
,
Ignacio Ricci-Cabello
,
Chris Gibbons
,
Jaheeda Gangannagaripalli
,
Ray Fitzpatrick
,
Nick Black
,
Joanne Greenhalgh
, and
Jose M Valderas
18 Jul 2016
Gene therapy: evidence, value and affordability in the US health care system
Grace Hampson
,
Adrian Towse
,
Steven D Pearson
,
William B Dreitlein
, and
Chris Henshall
16 Nov 2017
Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low- and middle-income countries
Bertalan Németh
,
Anett Molnár
,
Sándor Bozóki
,
Kalman Wijaya
,
András Inotai
,
Jonathan D Campbell
, and
Zoltán Kaló
15 Feb 2019
A 90-day episode-of-care cost analysis of robotic-arm assisted total knee arthroplasty
Christina L Cool
,
David J Jacofsky
,
Kelly A Seeger
,
Nipun Sodhi
, and
Michael A Mont
28 Jan 2019
Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study
Eugenio Mercuri
,
Francesco Muntoni
,
Andrés Nascimento Osorio
,
Már Tulinius
,
Filippo Buccella
,
Lauren P Morgenroth
,
Heather Gordish-Dressman
,
Joel Jiang
,
Panayiota Trifillis
,
Jin Zhu
,
Allan Kristensen
,
Claudio L Santos
,
Erik K Henricson
,
Craig M McDonald
,
Isabelle Desguerre
,
on behalf of the STRIDE
, and
CINRG Duchenne Natural History Investigators
30 Jan 2020
Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants
Victoria Allan
,
Sreeram V Ramagopalan
,
Jack Mardekian
,
Aaron Jenkins
,
Xiaoyan Li
,
Xianying Pan
, and
Xuemei Luo
18 Mar 2020
Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement
Patricia A Deverka
,
Danielle C Lavallee
,
Priyanka J Desai
,
Laura C Esmail
,
Scott D Ramsey
,
David L Veenstra
, and
Sean R Tunis
5 Mar 2012
Evaluating patient and stakeholder engagement in research: moving from theory to practice
Laura Esmail
,
Emily Moore
, and
Alison Rein
31 Mar 2015
The need to consider market access for pharmaceutical investment decisions: a primer
Sreeram V Ramagopalan
,
Catherine Bacon
,
Mel Walker
, and
Michael L Ryan
4 Apr 2025
Early mobilization in enhanced recovery after surgery pathways: current evidence and recent advancements
Reeana Tazreean
,
Gregg Nelson
, and
Rosie Twomey
20 Jan 2022
Will the UK–US pharmaceuticals deal really cause 229,000 excess deaths? A critical appraisal
Sreeram V Ramagopalan
and
Michael L Ryan
8 Sep 2026
How much do ex-US revenues make a difference for pharmaceutical investment returns?
Sreeram V Ramagopalan
,
Harshal Thaker
,
Mel Walker
, and
Om Narasimhan
2 Sep 2025
Why is the market design for innovative pharmaceuticals not well understood?
Francisco Olivença
,
Jose Diaz
,
Sreeram V Ramagopalan
, and
Louis P Garrison
10 Sep 2024
Access in all areas? A round-up of developments in market access and health technology assessment: part 14
Sreeram V Ramagopalan
and
Annie Jullien Pannelay
26 Mar 2026
Most-Favored-Nation pricing meets Joint Clinical Assessment: early evidence of compounding pressure on European drug launches
Sreeram V Ramagopalan
and
Michael L Ryan
19 Jun 2026
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 24
Paul Arora
and
Sreeram V Ramagopalan
9 Feb 2026